Study of surfactant level in cases of primary atrophic rhinitis

Journal of Laryngology and Otology

Volumn 114, Issue 4, 2000, Pages 254-259

  Sayed, Ramadan Hashem ^a   Abou Elhamd, Kamal Eldin A ^a   Abdel Kader, Mohamed ^a   Saleem, Tahia Hashem ^b  

^a Sohag University   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Atrophic; Rhinitis; Surface active agents

Indexed keywords

PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SPHINGOMYELIN; SURFACTANT;

ARTICLE; ATROPHIC RHINITIS; BIOCHEMISTRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; LIPOPROTEIN DEFICIENCY; MUCOCILIARY CLEARANCE; SYMPATHETIC FUNCTION;

EID: 0034010864     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215001905508     Document Type: Article

References (30)

1. King RJ, Clements JA. Surface active materials from dog lungs, composition and physiological correlations. Am J Physiol 1972;223:715-26
2. Zohar Y, Talmi YP, Strauss M, Finkelstein Y, Shvilli Y. Ozaena revisited. J Otolaryngol 1990;19:345-9
3. Ferguson JL, McCaffrey TV, Kern EB, Martin WJ 2nd. Effect of Klebsiella ozaenae on ciliary activity in vivo: implications in the pathogenesis of atrophic rhinitis. Otolaryngol Head Neck Surg 1990;102:207-11
4. Hagrass MA, Gamea AM, El-Sherief SG, El-Guindy AS, El Tatawi FA. Radiological and endoscopic study of the maxillary sinus in primary atrophic rhinitis. J Laryngol Otol 1992;106:702-3
5. Mokhtar M, Nasr AN, Osman M. Nasal atrophy - aetiopathogenesis. J Egyptian Med Assoc 1971;54:417-27
6. Han-Sen C. The ozaena problem. Clinical analysis of atrophic rhinitis in 100 cases. Acta Otolaryngol 1982;93:461-4
7. Ruskin SL. Differential diagnosis and therapy of atrophic rhinitis and ozaena. Arch Otolaryngol 1932;15:222-57
8. Fouad H, Afifi N, Fatthi A, El-Sheemy N, Iskander H, Abou-Saif MN. Altered cell mediated immunity in atrophic rhinitis. J Laryngol Otol 1980;94:507-14
9. Watson WE. Endocrines and nose. J Laryngol Otol 1952;66:29-38
10. Glew RH. Lipid metabolism II: Pathways of metabolism of special lipids. In: Devlin TM, ed. Textbook of Biochemistry with Clinical Correlations. 2nd edn. New York: A. Wiley, 1986;391-435
11. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993;147:218-33
12. Gunther A, Siebert C, Chmidt R, Ziegler S, Grimminger F, Yabut M, et al. Surfactant alternations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung oedema. Am J Respir Crit Care Med 1996;153:176-84
13. Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 1991;40:160-3
14. Sood SL, Balaraman V, Finn KC, Britton B, Uyehara CF, Easa D. Exogenous surfactants in a piglet model of acute respiratory distress syndrome. Am J Respir Crit Care 1996;153:820-8
15. Hills BA. Analysis of eustachian surfactant and its function as a release agent. Arch Otolaryngol 1984;110:3-9
16. Viggo SK, Hans FL, Torben B. Secretory otitis media - a question of surface activity in the eustachian tube? Acta Otolaryngol 1988;105:114-9
17. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system: Biochemical aspects and functional significance. Physiol Rev 1988;68:374-455
18. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81
19. Granner DK. Membranes: Structure, assembly and function. In: Murray RK, Mayes PA, Granner DK, Rodwell VW, eds. Harper's Biochemistry, 23rd edn. Norwalk, Los Altos: Lange, 1997:467-84
20. Dobbie JW, Tasiaux N, Meijers P, Anderson JD, Bodart C, Hind C, et al. Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease. Br J Rheumatol 1994;33:508-19
21. Arias-Diaz J, Vara E, Garcia C, Gomez M, Balibrea JL. Tumour necrosis factor-alpha inhibits synthesis of surfactants by isolated human type II pneumocytes. Eur J Surg 1993;159:541-9
22. Nagai A, Katayama M, Thurlbeck WM, Matsui R, Yasui S, Konno K. Effect of indomethacin on lung development in postnatal rats: possible role of prostaglandin in alveolar formation. Am J Physiol 1995;268:56-62
23. Viviano CJ, Bakewell WE, Dixon D, Dethloff LA, Hook GER. Altered regulation of surfactant phospholipid and protein A during acute pulmonary inflammation. Biochim Biophys Acta 1995;1259:235-44
24. Seeger W, Lepper H, Wolf HRD, Neuhof H. Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim Biophys Acta 1985;835:58-67
25. Seeger W, Gunther A, Walmrath HD, Grimminger F, Lasch HG. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. J Clin Invest 1993;71:177-90
26. Morgenroth K, Bolz J. Morphological features of the interaction between mucus and surfactant on the bronchial mucosa. Respiration 1985;47:225-31
27. Kakuta Y, Sasaki H, Takishima T. Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir Physiol 1991;83:313-21
28. Jonsson S, Musher DM, Goree A, Lawrence EC. Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis 1986;133:136-40
29. Johanson WG, Reynolds RC, Scott TC, Pierce AK. Connective tissue damage in emphysema. An electron microscopic study of papain-induced emphysema in rats. Am Rev Respir Dis 1973;107:589-95
30. Wilsher ML, Hughes DA, Haslam PL. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax 1988;43:354-9